AliveCor QT Service vs Cleerly LABS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AliveCor QT Service

by AliveCor

Cleerly LABS

by Cleerly

AI Verdict

While both tools leverage AI in cardiology, they address distinct clinical needs and utilize different diagnostic modalities. AliveCor QT Service focuses on cardiac safety by measuring QT intervals from ECGs to inform medication decisions, whereas Cleerly LABS analyzes CCTA images to detect and characterize coronary atherosclerosis and stenosis for heart disease management. They are adjacent in the broader cardiology space but are not direct competitors for the same diagnostic task.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if you need rapid, on-demand assessment of QT and QTc intervals to evaluate cardiac safety, particularly when considering or monitoring medications known to affect cardiac repolarization. This tool is ideal for healthcare professionals requiring immediate insights into potential drug-induced QT prolongation to inform prescribing decisions and mitigate arrhythmia risk.

View AliveCor QT Service →

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography to precisely detect, quantify, and characterize atherosclerosis and stenosis. This solution is best suited for clinicians focused on personalized heart disease management, risk stratification, and tracking the progression of coronary artery disease to guide long-term preventative and treatment strategies.

View Cleerly LABS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AliveCor QT Service	Cleerly LABS
Pricing	Varies by product and service, with subscription options available.	Per analysis
Deployment	Mobile app, cloud-based platform, EHR integration.	Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AliveCor QT Service	Cleerly LABS
Name	AliveCor QT Service	Cleerly LABS
Description	A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.	Cleerly LABS is an AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management.
Company	AliveCor	Cleerly
Primary Data Input	AliveCor 6-Lead ECGs (e.g., KardiaMobile 6L)	Coronary CT angiography (CCTA)
Key Functionality	Measures QT and QTc intervals (Bazett's and Fridericia's formulas); Utilizes AI and deep neural networks for ECG analysis; Provides instant QT measurements (as InstantQT).	AI-powered CCTA image analysis; Comprehensive coronary plaque assessment (volume, type); Stenosis detection and quantification; 3D visualization of coronary arteries.
Integration	Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms.	Integration with PACS, RIS, EHR via Cleerly Proxy.
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and Cleerly LABS.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of AliveCor QT Service and Cleerly LABS?

AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, primarily for cardiac safety assessment and to inform medication prescribing decisions. Cleerly LABS is an AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management and risk assessment.

What type of patient data or imaging is required for each tool?

AliveCor QT Service analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices. Cleerly LABS requires coronary CT angiography (CCTA) images for its analysis.

How do the pricing and reimbursement models differ between the two tools?

For AliveCor QT Service, pricing details require contacting the vendor. Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at a discounted rate of $750, and the CCTA scan cost is separate. Some insurance coverage is available for Cleerly LABS, but it often results in out-of-pocket expenses ranging from $1000-$1500 total, and it has received CPTu00ae I code approval and coverage from major payors.

What specific cardiac insights or measurements does each tool provide?

AliveCor QT Service provides instant QT and QTc interval measurements, utilizing Bazett's and Fridericia's formulas. Cleerly LABS offers comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with the Cleerly ISCHEMIA module), 3D visualization of coronary arteries, personalized heart disease risk assessment, and tracking of disease progression over time.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AliveCor QT Service or Cleerly LABS

Backers

Who funded each tool's parent company.